NASDAQ: AVIRAtea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?
Insider buying vs selling
Have Atea Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Vavricka | Chief Commercial Officer | 2025-01-31 | 11,517 | $3.06 | $35.24kSell |
| Andrea Corcoran | Chief Financial Officer Executive Vice President Legal and Secretary | 2025-01-31 | 16,102 | $3.06 | $49.27kSell |
| Wayne Foster | EVP Chief Accounting Officer | 2025-01-31 | 12,062 | $3.06 | $36.91kSell |
| Janet Mj Hammond | Chief Development Officer | 2025-01-31 | 14,134 | $3.06 | $43.25kSell |
| Maria Arantxa Horga | Chief Medical Officer | 2025-01-31 | 16,071 | $3.06 | $49.18kSell |
| Jeanpierre Sommadossi | President CEO and Chairman | 2025-01-31 | 88,601 | $3.06 | $271.12kSell |
| Franklin M. Berger | Director | 2025-01-16 | 10,000 | $3.36 | $33.61kBuy |
| Franklin M. Berger | Director | 2025-01-16 | 10,000 | $3.36 | $33.61kBuy |
| Franklin M. Berger | Director | 2025-01-15 | 15,000 | $3.19 | $47.88kBuy |
| Franklin M. Berger | Director | 2025-01-15 | 15,000 | $3.19 | $47.88kBuy |
AVIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AVIR insiders and whales buy or sell their stock.
AVIR Shareholders
What type of owners hold Atea Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.45% | 8,943,065 | $28.26M | Institution |
| Bml Capital Management LLC | 8.89% | 7,609,812 | $24.05M | Institution |
| Cormorant Asset Management LP | 7.49% | 6,411,355 | $20.26M | Insider |
| Jeanpierre Sommadossi | 7.21% | 6,166,965 | $19.49M | Insider |
| Fmr LLC | 7.03% | 6,018,019 | $19.02M | Institution |
| Andrew A. F. Hack | 6.56% | 5,615,659 | $17.75M | Insider |
| Tang Capital Management LLC | 5.61% | 4,800,000 | $15.17M | Institution |
| Vanguard Group Inc | 5.52% | 4,727,702 | $14.94M | Institution |
| Bain Capital Life Sciences Investors LLC | 2.90% | 2,485,638 | $7.85M | Institution |
| Geode Capital Management LLC | 2.31% | 1,977,337 | $6.25M | Institution |
AVIR vs Biotech Stocks
Atea Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.